Cite
HARVARD Citation
Ferrante, M. et al. (2022). Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study. European journal of gastroenterology & hepatology. 34 (6), pp. 646-654. [Online].